These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 3485506
21. In-vitro activity and beta-lactamase stability and inhibitory properties of a new penem antibiotic, Sch 34343. Neu HC, Chin NX, Labthavikul P. J Antimicrob Chemother; 1985 Jun; 15 Suppl C():25-37. PubMed ID: 3875603 [Abstract] [Full Text] [Related]
22. In vitro activity of ME1228, a new parenteral cephalosporin. Neu HC, Saha G, Chin NX. Antimicrob Agents Chemother; 1989 Aug; 33(8):1260-7. PubMed ID: 2802554 [Abstract] [Full Text] [Related]
27. Antibacterial activity of aztreonam: a synthetic monobactam. A comparative study with thirteen other antibiotics. Paradelis AG, Stathopoulos GA, Salpigides GN, Crassaris LG. Methods Find Exp Clin Pharmacol; 1983 Aug; 5(6):375-83. PubMed ID: 6684718 [Abstract] [Full Text] [Related]
28. Cefpodoxime: comparative antibacterial activity, influence of growth conditions, and bactericidal activity. Knothe H, Shah PM, Eckardt O. Infection; 1991 Aug; 19(5):370-6. PubMed ID: 1800379 [Abstract] [Full Text] [Related]
29. In vitro antibacterial activity and beta-lactamase stability of SY5555, a new oral penem antibiotic. Inoue E, Mitsuhashi S. Antimicrob Agents Chemother; 1994 Sep; 38(9):1974-9. PubMed ID: 7811005 [Abstract] [Full Text] [Related]
30. In vitro activity of a new broad spectrum, beta-lactamase-stable oral cephalosporin, cefixime. Neu HC. Pediatr Infect Dis J; 1987 Oct; 6(10):958-62. PubMed ID: 3696836 [Abstract] [Full Text] [Related]
33. In-vitro antibacterial activity of L-105, a new cephalosporin. Hikida M, Inoue M, Mitsuhashi S. J Antimicrob Chemother; 1986 Nov; 18(5):585-91. PubMed ID: 3492485 [Abstract] [Full Text] [Related]
34. [In vitro bacteriostatic activity of cefmenoxime (SCE 1365), cefotaxime and moxalactam]. Husson MO, Bryskier A, Izard D, Leclerc H. Pathol Biol (Paris); 1983 May; 31(5):347-50. PubMed ID: 6312395 [Abstract] [Full Text] [Related]
35. The antimicrobial activity and beta-lactamase stability of cefpirome, a new fourth-generation cephalosporin in comparison with other agents. Cheng AF, Ling TK, Lam AW, Fung KS, Wise R. J Antimicrob Chemother; 1993 May; 31(5):699-709. PubMed ID: 8335498 [Abstract] [Full Text] [Related]
37. In vitro studies on the antibacterial activities of YM-13115, a new broad-spectrum cephalosporin. Toda M, Arao N, Nohara C, Susaki K, Tachibana A. Antimicrob Agents Chemother; 1985 Apr; 27(4):565-9. PubMed ID: 3890729 [Abstract] [Full Text] [Related]
38. In vitro activity of cefcanel versus other oral cephalosporins. Chin NX, Gu JW, Neu HC. Eur J Clin Microbiol Infect Dis; 1991 Aug; 10(8):676-82. PubMed ID: 1748125 [Abstract] [Full Text] [Related]
39. BMY-28100, a new oral cephalosporin: antimicrobial activity against nearly 7,000 recent clinical isolates, comparative potency with other oral agents, and activity against beta-lactamase producing isolates. Jones RN, Barry AL. Diagn Microbiol Infect Dis; 1988 Jan; 9(1):11-26. PubMed ID: 3259489 [Abstract] [Full Text] [Related]